Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity

Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity

Background: Data published by task groups of the Ministry of Health of the Russian Federation, the European Society of Cardiology, and other medical associations and institutions show that chemotherapy-induced cardiomyopathy is still a challenging issue that requires further research.Objective: To c...

Full description

Bibliographic Details
Main Authors: A. A. Avagimyan, A. I. Trofimenko, M. Sheibani, L. V. Kakturskiy, O. I. Urazova, G. A. Navasardyan, Z. T. Jndoyan, N. V. Sulashvili, L. I. Gabunia, N. S. Gorgaslidze, F. M. Khamidova, L. A. Martemyanova, N. V. Pogosova, N. Sarrafzadegan
Format: Article
Language:Russian
Published: Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1 2023-11-01
Series:Инновационная медицина Кубани
Subjects:
cardiotoxicity
dapagliflozin
trimetazidine
oxidative stress
Online Access:https://www.innovmedkub.ru/jour/article/view/756

Internet

https://www.innovmedkub.ru/jour/article/view/756

Similar Items